Pierrel Logo

Pierrel

Pharmaceutical firm specializing in dental anesthetics and contract manufacturing.

PRL | XMIL

Overview

Corporate Details

ISIN(s):
IT0005549644
LEI:
8156002BC7CB6E3BD403
Country:
Italy
Address:
STRADA STATALE APPIA 7 BIS, 46/48, 81043 CAPUA

Description

Pierrel is a global pharmaceutical company specializing in oral health. With over 70 years of experience, the company focuses on the development, production, registration, and licensing of dental anesthetics and complementary medical devices. Its core expertise lies in the aseptic manufacturing of injectable drugs. The product portfolio includes a wide range of dental anesthetics marketed under its own brands, such as Orabloc®, Ubisestin™, Xylestesin™, and Mepivastesin™. In addition to its branded products, Pierrel offers medical devices for oral pathology screening, prevention, and regeneration. The company also provides contract manufacturing services to the pharmaceutical and life science industries. Its production facilities are authorized by major global regulatory agencies, including the EMA and FDA, ensuring compliance with high international quality standards.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2023-07-21 19:17
Pierrel S.p.A.: Internal Dealing
Italian 142.4 KB
2023-07-21 19:15
Pierrel S.p.A.: ESERCIZIO DEI DIRITTI DI OPZIONE DA PARTE DEGLI AZIONISTI RILEV…
Italian 244.6 KB
2023-07-07 19:53
Pierrel S.p.A.: MESSA A DISPOSIZIONE DEL KID (“KEY INFORMATION DOCUMENT”) RELAT…
Italian 253.0 KB
2023-07-07 16:52
Pierrel S.p.A.: AVVISO DI OFFERTA IN OPZIONE AI SENSI DELL’ART. 2441, COMMA 2, …
Italian 341.6 KB
2023-07-07 16:49
Pierrel S.p.A.: APPROVAZIONE E PUBBLICAZIONE DEL PROSPETTO INFORMATIVO RELATIVO…
Italian 237.2 KB
2023-07-05 21:29
Pierrel S.p.A.: IL CONSIGLIO DI AMMINISTRAZIONE APPROVA LE CONDIZIONI DELL’AUME…
Italian 297.7 KB
2023-06-23 15:26
Pierrel S.p.A.: Aggiornamento delle Informazioni essenziali relative al patto p…
Italian 170.5 KB
2023-06-20 15:48
Pierrel S.p.A.: PIERREL RICEVE L’AUTORIZZAZIONE PER IL COMMERCIO DI ORABLOC® IN…
Italian 180.2 KB
2023-06-20 09:59
Pierrel S.p.A.: PIERREL RICEVE L’AUTORIZZAZIONE PER IL COMMERCIO DI ORABLOC® IN…
Italian 180.1 KB
2023-06-19 16:47
Pierrel S.p.A.: RAGGRUPPAMENTO AZIONARIO – VALORIZZAZIONE DELLE FRAZIONI
Italian 223.1 KB
2023-06-14 17:41
Pierrel S.p.A.: Raggruppamento azionario
Italian 206.1 KB
2023-06-12 14:49
Pierrel S.p.A.: Aggiornamento delle Informazioni essenziali relative al patto p…
Italian 168.7 KB
2023-06-08 18:49
Pierrel S.p.A.: MODIFICA DELLO STATUTO SOCIALE E DEPOSITO DEL VERBALE DELL’ASSE…
Italian 218.2 KB
2023-06-08 18:46
Pierrel S.p.A.: Statuto Sociale
Italian 2.5 MB
2023-06-08 18:44
Pierrel S.p.A.: Verbale assemblea Straordinaria del 5 giugno 2023
Italian 5.4 MB

Automate Your Workflow. Get a real-time feed of all Pierrel filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Pierrel

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Pierrel via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

4BASEBIO PLC Logo
Manufactures GMP-grade synthetic DNA for next-generation therapeutics and vaccines.
United Kingdom
4BB
4D Molecular Therapeutics, Inc. Logo
Develops genetic medicines using AAV vectors for ophthalmology and pulmonology diseases.
United States of America
FDMT
4SC AG Logo
Biopharmaceutical company with no products under development or operational business.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops and commercializes medicines for infectious diseases, focusing on tropical illnesses.
United States of America
SXTP
89bio, Inc. Logo
Clinical-stage biopharma developing therapies for liver and cardiometabolic diseases.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Clinical-stage biopharma developing therapeutics for hunger and metabolic diseases.
United States of America
AARD
ABBOTT LABORATORIES Logo
Global healthcare company in medical devices, diagnostics, nutrition & pharmaceuticals.
United States of America
ABT
AbbVie Inc. Logo
A research-based biopharmaceutical company developing and manufacturing medicines.
United States of America
ABBV
AbCellera Biologics Inc. Logo
Discovers and develops antibody-based therapeutics using a proprietary platform.
United States of America
ABCL
Develops antibody-based therapeutics using CAR-T, NEST, and AffiMab platforms.
South Korea
174900

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.